Benzinga's Top Upgrades, Downgrades For December 21, 2017

Loading...
Loading...

Top Upgrades

  • Analysts at Bank of America upgraded Discovery Communications Inc. DISCA from Neutral to Buy. Discovery shares rose 1.88 percent to $22.79 in pre-market trading.
  • Buckingham upgraded JPMorgan Chase & Co. JPM from Neutral to Buy. JPMorgan shares rose 0.44 percent to $106.61 in pre-market trading.
  • Argus upgraded Darden Restaurants, Inc. DRI from Hold to Buy. Darden shares rose 0.50 percent to $96.15 in pre-market trading.
  • SunTrust Robinson Humphrey upgraded Park Hotels & Resorts Inc PK from Hold to Buy. Park Hotels shares rose 0.35 percent to close at $29.00 on Wednesday.
  • RBC Capital upgraded Coty Inc COTY from Sector Perform to Outperform. Coty shares gained 0.36 percent to close at $19.45 on Wednesday.
  • Analysts at Deutsche Bank upgraded Spirit Airlines Incorporated SAVE from Hold to Buy. Spirit Airlines shares rose 3.37 percent to $45.99 in pre-market trading.
  • Analysts at Wedbush upgraded Regions Financial Corp RF from Neutral to Outperform. Regions Financial shares fell 0.29 percent to close at $17.25 on Wednesday.
  • Buckingham upgraded Wells Fargo & Co WFC from Neutral to Buy. Wells Fargo shares slipped 0.36 percent to close at $60.14 on Wednesday.
  • Analysts at Deutsche Bank upgraded Allegiant Travel Company ALGT from Hold to Buy. Allegiant Travel shares fell 0.26 percent to close at $152.75 on Wednesday.


Top Downgrades

  • RBC Capital downgraded PG&E Corporation PCG from Outperform to Sector Perform. PG&E shares fell 11.58 percent to $45.20 in pre-market trading.
  • Analysts at Wedbush downgraded SunTrust Banks, Inc. STI from Outperform to Neutral. SunTrust shares fell 0.27 percent to close at $65.45 on Wednesday.
  • Jefferies downgraded Axovant Sciences Ltd AXON from Buy to Hold. Axovant Sciences shares fell 5.95 percent to $4.90 in pre-market trading.
  • Loop Capital downgraded Twenty-First Century Fox Inc FOXA from Hold to Sell. Twenty-First Century Fox shares fell 0.47 percent to $34.11 in pre-market trading.
  • Analysts at KLR Group downgraded Concho Resources Inc CXO from Buy to Hold. Concho Resources shares rose 0.13 percent to $147.00 in pre-market trading.
  • Buckingham downgraded Lazard Ltd LAZ from Buy to Neutral. Lazard fell 0.34 percent to $50.00 in pre-market trading.
  • Needham & Company downgraded Syntel, Inc. SYNT from Buy to Hold. Syntel shares fell 0.12 percent to close at $25.56 on Wednesday.


Top Initiations

  • KeyBanc initiated coverage on Regis Corporation RGS with a Sector Weight rating. Regis shares closed at $15.85 on Wednesday.
  • Stephens & Co. initiated coverage on Brooks Automation, Inc BRKS with an Overweight rating. The price target for Brooks Automation is set to $32. Brooks Automation shares closed at $24.68 on Wednesday.
  • H.C. Wainwright initiated coverage on La Jolla Pharmaceutical Company LJPC with a Buy rating. The price target for La Jolla Pharmaceutical is set to $62. La Jolla Pharmaceutical shares closed at $27.08 on Wednesday.
  • Analysts at Cowen & Co. initiated coverage on Mirati Therapeutics, Inc. MRTX with an Outperform rating. Mirati Therapeutics shares closed at $16.85 on Wednesday.
  • Analysts at B. Riley initiated coverage on Hasbro, Inc. HAS with a Buy rating. The price target for Hasbro is set to $108. Hasbro shares closed at $91.11 on Wednesday.
  • RBC Capital initiated coverage on Valley National Bancorp VLY with an Outperform rating. The price target for Valley National Bancorp is set to $14. Valley National Bancorp shares closed at $11.43 on Wednesday.
  • Analysts at KLR Group initiated coverage on Ring Energy Inc REI with a Buy rating. The price target for Ring Energy is set to $20. Ring Energy shares closed at $13.96 on Wednesday.
  • Analysts at Macquarie initiated coverage on Bright Horizons Family Solutions Inc BFAM with a Neutral rating. The price target for Bright Horizons Family is set to $95. Bright Horizons Family shares closed at $94.69 on Wednesday.
  • H.C. Wainwright initiated coverage on TrovaGene Inc TROV with a Buy rating. The price target for TrovaGene is set to $1. TrovaGene shares closed at $0.250 on Wednesday.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsBiotechnologyDowngradesHealth CareInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...